TrueMark Investments LLC Purchases 3,602 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

TrueMark Investments LLC lifted its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 54.1% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 10,260 shares of the healthcare conglomerate's stock after purchasing an additional 3,602 shares during the quarter. UnitedHealth Group accounts for about 1.7% of TrueMark Investments LLC's investment portfolio, making the stock its 17th largest holding. TrueMark Investments LLC's holdings in UnitedHealth Group were worth $5,190,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently bought and sold shares of the company. Howard Capital Management Group LLC purchased a new position in shares of UnitedHealth Group during the third quarter valued at $341,000. Principal Financial Group Inc. boosted its holdings in shares of UnitedHealth Group by 11.3% during the third quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate's stock worth $1,039,933,000 after purchasing an additional 180,479 shares during the period. Algert Global LLC acquired a new position in UnitedHealth Group in the 3rd quarter valued at approximately $1,763,000. Truvestments Capital LLC boosted its stake in shares of UnitedHealth Group by 13.0% during the 3rd quarter. Truvestments Capital LLC now owns 591 shares of the healthcare conglomerate's stock valued at $346,000 after buying an additional 68 shares during the period. Finally, Mirabella Financial Services LLP purchased a new stake in shares of UnitedHealth Group during the third quarter worth $235,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of the company's stock in a transaction on Friday, January 17th. The stock was bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now owns 4,500 shares of the company's stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.33% of the stock is currently owned by corporate insiders.

UnitedHealth Group Price Performance

NYSE:UNH traded down $0.25 during mid-day trading on Friday, hitting $515.47. The company's stock had a trading volume of 2,378,211 shares, compared to its average volume of 4,268,981. The stock has a fifty day moving average of $508.81 and a 200-day moving average of $544.24. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The company has a market capitalization of $471.51 billion, a price-to-earnings ratio of 33.26, a P/E/G ratio of 1.37 and a beta of 0.62. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to analysts' expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm's revenue for the quarter was up 6.8% on a year-over-year basis. During the same quarter last year, the company posted $5.83 EPS. As a group, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.63%. UnitedHealth Group's payout ratio is 54.19%.

Analysts Set New Price Targets

A number of research firms have recently weighed in on UNH. Deutsche Bank Aktiengesellschaft raised their price target on UnitedHealth Group from $595.00 to $625.00 and gave the stock a "buy" rating in a research note on Tuesday, December 3rd. HSBC upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price target on the stock in a research note on Friday, January 10th. Stephens upped their price objective on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an "overweight" rating in a report on Thursday, December 5th. StockNews.com raised UnitedHealth Group from a "hold" rating to a "buy" rating in a research report on Thursday, January 23rd. Finally, Barclays reduced their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating for the company in a research note on Friday, January 17th. Twenty analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Buy" and a consensus price target of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.